Emgality Coupons & Savings Card – Discount Prices from $739.06
My prescription
Edit
1ML of 120MG/ML, Emgality (1 Pen)
Select pharmacy
Albertsons
$739.06
COUPON PRICE
Walgreens
$761.88
COUPON PRICEEmgality savings card
Show this card to your pharmacistAlbertsons
$739.06
BIN
ID
PCN
GRP
015995
LHKKX578812
GDC
DR33
Powered by
Related CGRP receptor antagonists prescriptions
More prescriptions for migraine
Related CGRP receptor antagonists prescriptions
More prescriptions for migraine
Price history for Emgality
1 Pen, 1ML of 120MG/ML
Average retail price for Emgality
Average SaveHealth price for Emgality
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Emgality dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 120MG/ML | 1 Pen | $761.88 | $761.88 |
Emgality Warnings
When considering the use of Emgality (galcanezumab), it is essential to be aware of the potential risks and safety precautions associated with this medication. Below are critical safety details that should be reviewed. If you have any concerns, please consult your healthcare provider.
Serious Allergic Reactions: Emgality (galcanezumab) may cause severe allergic reactions, including anaphylaxis, which could manifest several days after administration. Symptoms may include:
- Hives (red, raised skin patches that are warm or itchy)
- Rash
- Facial and eye swelling
- Throat swelling
- Breathing difficulties
- Wheezing or coughing
- Swallowing difficulties
- Vomiting
- Diarrhea
- Fainting If any of these symptoms occur, discontinue Emgality (galcanezumab) immediately and seek medical assistance.
Antibody Formation: There is a possibility that your body may develop antibodies against Emgality (galcanezumab). Clinical studies indicate that approximately 12% of individuals developed these antibodies after one year of treatment. The implications of antibody development on the medication’s safety and effectiveness are still under investigation. It is advisable to discuss any concerns regarding antibody formation with your healthcare provider.
Please note that no specific contraindications have been identified for Emgality (galcanezumab) at this time.
Emgality Side Effects
When using this medication, some individuals may experience common, generally mild side effects. These include reactions at the injection site such as pain, itching, redness, warmth, or swelling, which affect up to 20% of users. Additionally, sore throat and runny nose can occur in up to 18% of people, and back pain is reported by up to 10%. These symptoms are usually temporary, but if they persist or worsen, consulting a healthcare provider is advisable. Other side effects that some users might encounter include nausea, joint and muscle pain, dizziness, and weight gain. While these are not uncommon, it's important to monitor their progression and discuss them with a healthcare provider if they become bothersome. More severe side effects, although rare, require immediate medical attention. These include blue fingers or toes, cold hands or feet, and significant increases in blood pressure. A very serious allergic reaction may involve symptoms such as hives, swelling of the face, tongue, or throat, severe dizziness, or difficulty breathing. If any of these symptoms occur, it is crucial to seek urgent medical care to ensure safety. Always be attentive to your health and report any unusual symptoms to your healthcare provider.
Emgality Interactions
Emgality (galcanezumab-gnlm) is a medication prescribed to help prevent migraine episodes and treat cluster headaches. Understanding how it interacts with other substances is important for safe and effective use.
Drug Interactions:
Emgality is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), a protein involved in migraine and cluster headache pathways. Due to its specific mechanism, Emgality is not expected to interact with most other medications. Clinical studies did not identify significant drug interactions, and no pharmacokinetic interactions are anticipated based on its characteristics. However, it's important to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, to ensure comprehensive care.
Alcohol and Emgality:
There are no known direct interactions between Emgality and alcohol. However, alcohol can trigger migraine or cluster headache episodes in some individuals. If alcohol is a known trigger for your headaches, it may be advisable to limit or avoid its consumption during Emgality treatment.
Health Conditions:
Before starting Emgality, discuss your full medical history with your healthcare provider. While Emgality is generally well-tolerated, certain conditions may require special consideration. For instance, if you have a history of allergic reactions to medications, inform your doctor, as Emgality can cause allergic responses in rare cases. Additionally, if you have high blood pressure or Raynaud's phenomenon, your doctor may monitor you more closely during treatment.
Pregnancy and Breastfeeding:
The safety of Emgality during pregnancy and breastfeeding has not been fully established. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider to weigh the potential benefits and risks of using Emgality.
General Recommendations:
To minimize the risk of interactions and side effects:
Keep an updated list of all medications and supplements you are taking and share it with your healthcare provider.
Follow your prescribed dosage and administration instructions carefully.
Report any unusual symptoms or side effects to your doctor promptly.
By staying informed and maintaining open communication with your healthcare team, you can use Emgality safely and effectively as part of your headache management plan.
What exactly does Emgality do?
Emgality is a medication used to prevent migraine headaches in adults. It works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP), which is involved in the development of migraine attacks. By inhibiting this protein, Emgality helps reduce the frequency and severity of migraines.
How much weight gain does Emgality cause?
Emgality is not commonly associated with significant weight gain. While individual responses to medications can vary, weight gain is not listed as a prevalent side effect of Emgality. If there are concerns about weight changes while using Emgality, it is advisable to consult with a healthcare provider.
How much does Emgality cost?
The cost of Emgality can vary depending on factors such as insurance coverage, pharmacy location, and any available discounts or patient assistance programs. Without insurance, the price can be quite high, often several hundred dollars per month. It is advisable for individuals to check with their insurance provider and local pharmacies for specific pricing and potential financial assistance options.
Is Emgality better than Botox?
The effectiveness of Emgality versus Botox for migraine prevention can vary depending on the individual. Emgality is a monoclonal antibody specifically targeting the CGRP pathway, while Botox is a neurotoxin that works by blocking nerve signals. Some patients may respond better to one treatment over the other. It is important for individuals to consult with their healthcare provider to determine which treatment is more suitable for their specific condition and medical history.
Can Emgality cause bloating?
Bloating is not commonly reported as a side effect of Emgality (galcanezumab-gnlm). However, side effects can vary among individuals. If someone experiences bloating or any other unusual symptoms while taking Emgality, it is advisable to consult with a healthcare provider to determine the cause and appropriate action.